Highlands Oncology Group - Rogers is a clinical research site located in Rogers, Arkansas, United States 72758.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Highlands Oncology Group - Rogers has participated in 25 clinical trials with 24 currently active.
Therapeutic areas: Prostate Carcinoma, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma.
Sponsors: ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), SWOG Cancer Research Network.
Trust Score: 79/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Highlands Oncology Group - Rogers has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Highlands Oncology Group - Rogers has 25 clinical trials on record, with 24 currently active. Their work covers Prostate Carcinoma, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma.
Highlands Oncology Group - Rogers has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.